Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Joseph C. Galante, insider at Cumberland Pharmaceuticals
Joseph C. Galante Insider Alerts

Get notified the next time Joseph C. Galante buys or sells Cumberland Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

Joseph C. Galante Insider Information

Mr. Galante is a music industry executive with extensive experience that scans a celebrated career. He is accredited with developing the careers of Alabama, Dave Mathews Band, Dolly Parton, Kenny Chesney, Brad Paisley, Martina McBride, Carrie Underwood, Clint Black, Miranda Lambert, and the Judds, among others. His successful business track record, entrepreneurial and public company experience make him a valuable member of our board. Mr. Galante began at RCA Records in New York, followed by a transfer to RCA Nashville where he served as a director at the label, followed by the role of Vice President of Promotion and Marketing. At the age of 32 he became the youngest person ever named to run a major country record label. In 1990 he was appointed President of RCA Records US based in New York. He returned to Nashville as Chairman to run the RCA and BNA labels in Nashville. Under his leadership, RCA Records was the number one country label for eleven consecutive years. He then served as Chairman of Sony Music Nashville for six years. He was presented with the Bob Kingsley Living Legend Award by the Opry Trust to honor his work for country music. Mr. Galante is currently a member of the Board of Directors of Pinnacle Financial Partners whose shares are listed on the NASDAQ stock exchange, the Country Music Association, and serves as the Chair of the CMA Foundation.

What is Joseph C. Galante's net worth?

The estimated net worth of Joseph C. Galante is at least $93,282.57 as of February 9th, 2021. Mr. Galante owns 20,323 shares of Cumberland Pharmaceuticals stock worth more than $93,283 as of December 5th. This net worth approximation does not reflect any other investments that Mr. Galante may own. Learn More.

How do I contact Joseph C. Galante?

The corporate mailing address for Mr. Galante and other Cumberland Pharmaceuticals executives is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. Cumberland Pharmaceuticals can also be reached via phone at (615) 255-0068 and via email at [email protected]

Has Joseph C. Galante been buying or selling shares of Cumberland Pharmaceuticals?

During the past quarter, Joseph C. Galante has bought $5,023.00 in Cumberland Pharmaceuticals stock. Most recently, on Friday, October 29th, Joseph C. Galante bought 142 shares of Cumberland Pharmaceuticals stock. The stock was acquired at an average cost of $2.72 per share, with a total value of $386.24.

Who are Cumberland Pharmaceuticals' active insiders?

Cumberland Pharmaceuticals' insider roster includes Martin Cearnal (SVP), Joseph Galante (Director), A. J. Kazimi (CEO), A.J. Kazimi (CEO), Kenneth Krogulski (Director), and William Sumas (EVP).

Are insiders buying or selling shares of Cumberland Pharmaceuticals?

In the last twelve months, Cumberland Pharmaceuticals insiders bought shares 150 times. They purchased a total of 20,900 shares worth more than $60,160.22. In the last twelve months, insiders at the specialty pharmaceutical company sold shares 1 times. They sold a total of 1,830 shares worth more than $42,986.70. The most recent insider tranaction occured on October, 29th when Director Joseph C Galante bought 142 shares worth more than $386.24. Insiders at Cumberland Pharmaceuticals own 41.2 % of the company.

Information on this page was last updated on 10/29/2021.

Joseph C. Galante Insider Trading History at Cumberland Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/29/2021Buy142$2.72$386.24View SEC Filing Icon  
10/27/2021Buy142$2.61$370.62View SEC Filing Icon  
10/25/2021Buy142$2.64$374.88View SEC Filing Icon  
10/22/2021Buy142$2.66$377.72View SEC Filing Icon  
10/20/2021Buy142$2.63$373.46View SEC Filing Icon  
10/18/2021Buy142$2.75$390.50View SEC Filing Icon  
10/15/2021Buy142$2.76$391.92View SEC Filing Icon  
10/13/2021Buy142$2.71$384.82View SEC Filing Icon  
10/11/2021Buy142$2.73$387.66View SEC Filing Icon  
10/8/2021Buy142$2.84$403.28View SEC Filing Icon  
10/6/2021Buy142$2.76$391.92View SEC Filing Icon  
10/4/2021Buy142$2.87$407.54View SEC Filing Icon  
10/1/2021Buy142$2.69$381.98View SEC Filing Icon  
9/29/2021Buy142$2.82$400.44View SEC Filing Icon  
9/27/2021Buy142$2.79$396.18View SEC Filing Icon  
9/24/2021Buy142$2.74$389.08View SEC Filing Icon  
9/22/2021Buy142$2.76$391.92View SEC Filing Icon  
9/20/2021Buy142$2.82$400.44View SEC Filing Icon  
9/17/2021Buy142$2.85$404.70View SEC Filing Icon  
9/15/2021Buy142$2.86$406.12View SEC Filing Icon  
9/13/2021Buy142$2.96$420.32View SEC Filing Icon  
9/9/2021Buy142$2.77$393.34View SEC Filing Icon  
9/7/2021Buy142$2.79$396.18View SEC Filing Icon  
9/3/2021Buy142$2.85$404.70View SEC Filing Icon  
9/1/2021Buy142$2.88$408.96View SEC Filing Icon  
8/26/2020Buy225$3.29$740.2520,992View SEC Filing Icon  
8/21/2020Buy375$3.35$1,256.2520,992View SEC Filing Icon  
8/14/2020Buy375$3.44$1,290.0020,992View SEC Filing Icon  
8/7/2020Buy375$3.42$1,282.5020,992View SEC Filing Icon  
7/31/2020Buy375$3.26$1,222.5020,992View SEC Filing Icon  
7/24/2020Buy375$3.33$1,248.7520,992View SEC Filing Icon  
7/17/2020Buy375$3.29$1,233.7520,992View SEC Filing Icon  
7/10/2020Buy375$3.31$1,241.2520,992View SEC Filing Icon  
7/2/2020Buy300$3.34$1,002.0020,992View SEC Filing Icon  
6/26/2020Buy375$3.37$1,263.7520,992View SEC Filing Icon  
6/19/2020Buy375$3.41$1,278.7520,992View SEC Filing Icon  
6/12/2020Buy225$3.37$758.2520,992View SEC Filing Icon  
6/8/2020Buy75$3.54$265.5017,767View SEC Filing Icon  
6/5/2020Buy75$3.44$258.0017,767View SEC Filing Icon  
6/3/2020Buy75$3.29$246.7517,767View SEC Filing Icon  
6/1/2020Buy75$3.45$258.7517,767View SEC Filing Icon  
5/28/2020Buy75$3.34$250.5017,767View SEC Filing Icon  
5/26/2020Buy75$3.59$269.2517,767View SEC Filing Icon  
5/22/2020Buy75$3.61$270.7517,767View SEC Filing Icon  
5/20/2020Buy75$3.77$282.7517,767View SEC Filing Icon  
5/18/2020Buy75$3.82$286.5017,767View SEC Filing Icon  
5/15/2020Buy75$3.76$282.0017,767View SEC Filing Icon  
5/13/2020Buy150$3.93$589.5017,767View SEC Filing Icon  
5/11/2020Buy150$4.02$603.0017,767View SEC Filing Icon  
5/7/2020Buy150$3.97$595.5017,767View SEC Filing Icon  
5/5/2020Buy150$3.99$598.5017,767View SEC Filing Icon  
5/1/2020Buy150$4.01$601.5017,767View SEC Filing Icon  
4/29/2020Buy150$4.01$601.5017,767View SEC Filing Icon  
4/27/2020Buy150$4.02$603.0017,767View SEC Filing Icon  
4/23/2020Buy150$4.03$604.5017,767View SEC Filing Icon  
4/21/2020Buy150$4.03$604.5017,767View SEC Filing Icon  
4/17/2020Buy150$4.04$606.0017,767View SEC Filing Icon  
4/15/2020Buy150$4.05$607.5017,767View SEC Filing Icon  
4/13/2020Buy75$4.03$302.2517,767View SEC Filing Icon  
7/24/2019Buy1,680$6.23$10,466.4011,618View SEC Filing Icon  
6/12/2019Buy1,682$6.36$10,697.529,975View SEC Filing Icon  
4/4/2019Buy241$6.19$1,491.798,732View SEC Filing Icon  
4/1/2019Buy382$5.99$2,288.188,732View SEC Filing Icon  
See Full Table

Joseph C. Galante Buying and Selling Activity at Cumberland Pharmaceuticals

This chart shows Joseph C Galante's buying and selling at Cumberland Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cumberland Pharmaceuticals Company Overview

Cumberland Pharmaceuticals logo
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.
Read More

Today's Range

Now: $4.59
Low: $3.87
High: $4.87

50 Day Range

MA: $2.80
Low: $2.20
High: $5.03

2 Week Range

Now: $4.59
Low: $2.20
High: $5.48


8,307,687 shs

Average Volume

12,155,066 shs

Market Capitalization

$67.98 million

P/E Ratio


Dividend Yield



Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!